Perseris

News

Regulators authorities in the US have approved Indivior’s long-acting injectable treatment for adults with schizophrenia.

Patients

Rebecca Guntern, Sandoz' CCO, discusses the ‘golden decade’ for generics and biosimilars as so many blockbuster drugs come off patent.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.